Products and Services

Device company RxPack has joined the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) as an associate member, the company said. RxPack is a joint venture between Lindal Group and Coster Group that was formed in 2021 to distribute metered dose inhaler and nasal spray devices as well as Coster's aerosol filling … [Read more...] about RxPack joins IPAC-RS as associate member

Gerresheimer has announced that it will manufacture supplies of Iconovo's IcoOne dry powder inhaler for Phase 3 trials of ISR's intranasal COVID-19 vaccine and has started the design process for molding and manufacturing the device. In March 2021, Iconovo announced that it would develop an inhaled vaccine for ISR, and in July 2021, Icovono said that it was developing … [Read more...] about Gerresheimer to manufacture ICOone DPI for Phase 3 trials of ISR’s intranasal COVID-19 vaccine

CDMO Upperton Pharma Solutions, which recently launched a new nasal delivery development platform, has announced that it will invest £15 million in a new 50,000 sq ft facility in Nottingham, UK that will include new laboratory space and 10 times more GMP manufacturing space than the company has currently. The new facility will also have the ability to handle highly … [Read more...] about Upperton Pharma Solutions announces plans to build new facility

CDMO Lonza has announced that it is adding dry powder inhaler testing capabilities at its facility in Tampa, FL, USA for increased DPI development capacity. Lonza, which established a Center of Excellence for DPI particle engineering and formulation in Bend, OR, USA in 2020, said that the new laboratories in the Florida location will include capabilities for handling … [Read more...] about Lonza announces expansion of DPI testing capacity

Aston University spin out Aston Particle Technologies (APT) has closed a £1 million funding round according to lead investor DSW Ventures. The funding will be used for scale up of APT's isothermal dry particle coating (iDPC) technology, which DSW said is useful for high dose DPI formulations among other uses. DSW explained that the expanded cGMP capacity is necessary … [Read more...] about Aston Particle Technologies gets £1 million in funding

Scottish nebulizer developer Nebu-Flow has raised £1.7 million "to continue the commercialization and delivery of next generation respiratory pharmaceuticals," the company has announced on social media. The funding round was led by Foresight Williams Technology. Nebu-Flow was spun out from the University of Glasgow in 2019 to develop a device based on surface acoustic … [Read more...] about Nebu-Flow closes £1.7 million funding round

Zeteo Biomedical has announced the launch of its ZEOx1 OrionMRQ metered dose nasal device for delivery of drugs and vaccines. Zeteo's ZEOx1 devices are designed for intranasal delivery of liquid formulations, and its ZEOx2 devices are designed for intranasal delivery of powders, reconstituted powders, or multiple liquid formulations. In November 2020, Zeteo said that … [Read more...] about Zeteo Biomedical launches ZEOx1 OrionMRQ nasal delivery device

DPI developer Iconovo has announced that Galenica AB will offer cGMP manufacturing of Iconovo's ICOone single dose disposable DPI for clinical trials, so that customers wanting to develop an inhaled drug delivered by the ICOone device have an accelerated option for producing clinical trial supplies. According to the announcement, close cooperation between the … [Read more...] about Galenica to provide GMP manufacturing for clinical trial supplies of Iconovo’s ICOone inhaler